In the race to vaccinate people for Covid-19, everyone agrees front-line health workers, the elderly and those with pre-existing conditions should get priority. But one vital group is being overlooked. Even worse, some are criticizing efforts to vaccinate them as some sort of effort to “cut the line.”
I’m referring to the thousands of people working to produce critical vaccines, medications and diagnostics for Covid-19. In addition to Pfizer and Moderna, my company, Emergent BioSolutions, has been ramping up manufacturing...
